Safety and Acceptability Study of Oral Emtricitabine/Tenofovir Disoproxil Fumarate Tablet and Rectally-Applied Tenofovir Reduced-Glycerin 1% Gel

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Division of AIDS
Information provided by (Responsible Party):
CONRAD
ClinicalTrials.gov Identifier:
NCT01687218
First received: August 27, 2012
Last updated: April 16, 2015
Last verified: April 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: June 2015
  Estimated Primary Completion Date: June 2015 (Final data collection date for primary outcome measure)